Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  De Chiara, Loretta ^a   Rodríguez Piñeiro, Ana M ^a,d   Cordero, Oscar J ^b   Vázquez Tuñ, Lidia ^c   Ayude, Daniel ^a   Rodríguez Berrocal, Francisco J ^a   De La Cadena, María Páez ^a  

^a UNIVERSITY OF VIGO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOHYDRATE ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DIPEPTIDYL PEPTIDASE IV; TUMOR MARKER; DPP4 PROTEIN, HUMAN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CLINICAL ARTICLE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; DISEASE SURVEILLANCE; EARLY DIAGNOSIS; EARLY INTERVENTION; ENZYME BLOOD LEVEL; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; JEJUNUM METASTASIS; LIVER METASTASIS; LUNG METASTASIS; MALE; METASTASIS; MIDDLE AGED; PALLIATIVE THERAPY; PERITONEUM METASTASIS; PILOT STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPLEEN METASTASIS; TREATMENT DURATION; BLOOD; COLORECTAL NEOPLASMS; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; SECONDARY;

AGED; COLORECTAL NEOPLASMS; DIPEPTIDYL PEPTIDASE 4; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84925399166     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107470     Document Type: Article

References (35)

1. Rodríguez-Moranta F, Saló J, Arcusa A, Boadas J, Piñol V, et al. (2006) Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: A prospective, multicenter, randomized, controlled trial. J Clin Oncol 24: 386-393.
2. Scheer A, Auer RA (2009) Surveillance after curative resection of colorectal cancer. Clin Colon Rectal Surg 22: 242-250.
3. Jeffery M, Hickey BE, Hider PN (2007) Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 24: CD002200.
4. Renehan AG, Egger M, Saunders MP, O'Dwyer ST (2002) Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 324: 813.
5. Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, et al. (2006) Guidelines for colonoscopy surveillance after cancer resection: A consensus update by the American Cancer Society and U.S. Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin 56: 160-167.
6. Duffy MJ, Lamerz R, Haglund C, Nicolini A, Kalousová M, et al. (2014) Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int J Cancer 134: 2513-2522.
7. Tsikitis VL, Malireddy K, Green EA, Christensen B, Whelan R, et al. (2009) Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial. J Clin Oncol 27: 3671-3676.
8. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, et al. (2006) ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24: 5313-5327.
9. Griesenberg D, Nürnberg R, Bahlo M, Klapdor R (1999) CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Anticancer Res 19: 2443- 2450.
10. Goldstein MJ, Mitchell EP (2005) Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest 23: 338-351.
11. Hammond K, Margolin DA (2007) The role of postoperative surveillance in colorectal cancer. Clin Colon Rectal Surg 20: 249-254.
12. Chen T, Smyth D, Abbott CA (2004) CD26. J Biol Regul Homeost Agents 18: 47-54.
13. Durinx C, Lambeir AM, Bosmans E, Falmagne JB, Berghmans R, et al. (2000) Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur J Biochem 267: 5608-5613.
14. Cordero OJ, Salgado FJ, Nogueira M (2009) On the origin of serum CD26 and its altered concentration in cancer patients. Cancer Immunol Immunother 58: 1723-1747.
15. Cordero OJ, Ayude D, Nogueira M, Rodriguez-Berrocal FJ, de la Cadena MP (2000) Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer. Br J Cancer 83: 1139-1146.
16. De Chiara, L, Rodríguez-Piñeiro AM, Rodríguez-Berrocal FJ, Cordero OJ, Martínez-Ares D, et al. (2010) Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas. BMC Cancer 10: 333.
17. Shimwell NJ, Wei W, Wilson S, Wakelam MJ, Ismail T, et al. (2010) Assessment of novel combinations of biomarkers for the detection of colorectal cancer. Cancer Biomark 7: 123-132.
18. Tao S, Haug U, Kuhn K, Brenner H (2012) Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for noninvasive colorectal cancer screening. Br J Cancer 106: 1424-1430.
19. De Chiara L, Rodríguez-Piñeiro AM, Cordero OJ, Rodríguez-Berrocal FJ, Ayude D, et al. (2009) Soluble CD26 levels and its association to epidemiologic parameters in a sample population. Dis Markers 27: 311-316.
20. Cordero OJ, Imbernon M, De Chiara LD, Martinez-Zorzano VS, Ayude D, et al. (2011) Potential of soluble CD26 as a serum marker for colorectal cancer detection. World J Clin Oncol 2: 245-261.
21. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, et al. (1993) An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 270: 943-947.
22. Kievit J (2002) Follow-up of patients with colorectal cancer: numbers needed to test and treat. Eur J Cancer 38: 986-999.
23. Lambeir AM, Durinx C, Scharpé S, De Meester, I (2003) Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 40: 209-294.
24. Mayo SC, Pawlik TM (2009) Current management of colorectal hepatic metastasis. Expert Rev Gastroenterol Hepatol 3: 131-144.
25. Rotolo N, De Monte, L, Imperatori A, Dominioni L (2007) Pulmonary resections of single metastases from colorectal cancer. Surg Oncol 16 Suppl 1: 141-144.
26. Boonacker E, Van Noorden, CJF (2003) The multifunctional or moonlighting protein CD26/DPPIV. Eur J Cell Biol 82: 53-73.
27. Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, et al. (2011) Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60: 1917-1925.
28. Raschke S, Eckardt K, Bjørklund Holven K, Jensen J, Eckel J (2013) Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells. PLoS ONE 8: e62008.
29. Cavallo F, De Giovanni C, Nanni P, Forni G, Lollini P-L (2011) 2011: the immune hallmarks of cancer. Cancer Immunol Immunother 60: 319-326.
30. Ten Kate J, van den Ingh, HF, Khan PM, Bosman FT (1986) Adenosine deaminase complexing protein (ADCP) immunoreactivity in colorectal adenocarcinoma. Int J Cancer 37: 479-485.
31. Pang R, Law WL, Chu AC, Poon JT, Lam CS, et al. (2010) A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 6: 603-615.
32. Uematsu T, Tanaka H, Yamaoka M, Furusawa K (2004) Effects of oral squamous cell carcinoma-derived TGF-beta1 on CD26/DPPIV expression in T cells. Anticancer Res 24: 619-624.
33. Lam CS-C, Cheung AH-K, Wong SK-M, Wan TM-H, Ng L, et al. (2014) Prognostic Significance of CD26 in Patients with Colorectal Cancer. (2014) PLoS ONE 9: e98582.
34. Dang NH, Morimoto C (2002) CD26: An expanding role in immune regulation and cancer. Histol Histopathol 17: 1213-1226.
35. Chen WT, Kelly T (2003) Seprase complexes in cellular invasiveness. Cancer Metastasis Rev 22: 259-269.